Loading...

Loading...

Donanemab Gains EMA Panel Support for Alzheimer’s Treatment
Donanemab Gains EMA Panel Support for Alzheimer’s Treatment
By MBN Staff - Mon, 07/28/2025 - 08:59
Donanemab receives EMA panel’s recommendation for treating early Alzheimer’s, with implications for healthcare systems across the world.

Featured content

Most popular

Partnership Content

Cluster Automotriz Nuevo Leon
https://mexicobusiness.news/tag/donanemab
More Health
Lilly's Donanemab Receives FDA Unanimous Backing
Lilly's Donanemab Receives FDA Unanimous Backing
By MBN Staff - Tue, 06/11/2024 - 16:53
Eli Lilly's Alzheimer's drug donanemab gains unanimous support from an FDA panel, moving closer to potential approval.